Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Japanese Drug Makers Conduct MRCTs in More Countries, but Japan Ranks Just 24th as Trial Location: JPMA Survey
March 18, 2014
- JPWA Members to Display Delivery Prices without Tax from October
March 14, 2014
- 3,551 Contract Medical Sales Reps Work in Japan, Up 5.5%: Survey
March 13, 2014
- PhRMA Issues Principles on Investigator-Initiated Studies, Urges Drug Makers Not to Offer Labor
March 12, 2014
- PhRMA “Disappointed” by Rule Changes for Foreign Price Adjustments: New Japan Committee Chair
March 12, 2014
- FPMAJ Generic Guidelines Urge Makers to Create “Stable Supply” Officer Post
March 7, 2014
- JPMA Requests Takeda to Submit Report over CASE-J Issue
March 6, 2014
- Penalty for Lengthy Drug Price Haggling – Interview 3: JMA Exec Suzuki Calls for Cooperation to Defend Universal Healthcare
March 3, 2014
- Medwatcher Opposes Resumption of Active Recommendation for HPV Vaccines by Government
February 26, 2014
- Tokyo Pharmacist Head Yamamoto Elected Next President of JPA
February 26, 2014
- Penalty for Lengthy Drug Price Haggling – Interview 2: “Rule Could Ruin Trust with Wholesalers,” Says NPhA Chief Nakamura
February 25, 2014
- Rule to Reduce Medical Fees at Hospitals with Low Price Settlement Rates Reflects Chuikyo’s Concerns about Profits: Kenporen
February 24, 2014
- NPhA Member Pharmacies Prepping to Form Bidding Body for Drug Purchasing, Launch Slated in Late March
February 20, 2014
- Hospitals Will “Respond Calmly” to Rule to Reduce Medical Fees Claimed by Facilities with Low Price Settlement Rates: Presidents of JHA, AJHA
February 19, 2014
- NPhA Objects to JPA Response on Rule to Reduce Dispensing Fees Claimed by Pharmacies with Low Price Settlement Rates
February 18, 2014
- MSD’s Alvarez Moved Up to Chair of PhRMA Japan Committee
February 13, 2014
- Prof. Tsuchiya Slams Kowa’s Livalo Trademark Suit
February 10, 2014
- July-September Generic Share at 43.1% under New Formula: JGA
February 6, 2014
- JPWA to File Notification to Form Cartel for Uniform Tax Display Method
January 31, 2014
- JPMA Drafting New Rules that Would Restrict Grants and Endowments by Drug Makers to Research Not Involving Their Own Products
January 28, 2014
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…